Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
This research evaluates a multifaceted intervention to improve lipid-lowering therapy among patients hospitalized for Type I myocardial infarction in the Asia-Pacific region. The study compares an early intervention group receiving the approach at baseline to a late intervention group initially receiving standard care. It is a multinational, randomized, parallel-group study aiming to enhance guideline-directed lipid management through patient and clinician engagement. The intervention involves a cholesterol score card used by both patients and their clinicians to document LDL cholesterol levels, adherence to therapy, management decisions, and current prescribed treatments. Risk stratification using the SMART Risk score and Lpa measurement is shared with both patients and their primary care clinicians. The late intervention group receives standard care for the first 6 months, including lipid profile reports to their doctor, before receiving the intervention at 6 months. Participants are involved for 12 months, with the first 6 months focusing on either early intervention or standard care, followed by crossover for the late group. Follow-up visits include updating the cholesterol score card at clinical appointments. Researchers measure the proportion of patients achieving LDL cholesterol below 1.4 mmolL at 6 and 12 months, therapy intensification, medication adherence, and patient activation. The study monitors outcomes through routine clinical care, aiming to reflect real-world practice.